Total Funding
31
8
Total FundingDebt Financing raised
Growth Score 31 in past quarter
-1 pts
Heat Score 8 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
508873
Romark Global Pharma is a pharmaceutical company that develops and distributes pharmaceutical drugs.
Jean-François Rossignol: Chief Medical & Science Officer- Marc Ayers: Manager and Chief Executive Officer
About the Company
Romark Global Pharma is a pharmaceutical company that develops and distributes pharmaceutical drugs.
Romark is a pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases and cancers. The company's people share a passion for scientific discovery and a
desire to make a difference in the world's health. Throughout all phases of drug discovery and development, we are teamed in a quest to provide new treatments for diseases that impact the lives of people worldwide.
